This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L04AA31
1 out of 7 registries used, show all original rules.
328
Check minimum number of events
Min. number of events
3
328
Include endpoints None
328
Remove individuals based on genotype QC
312
MSMED_TERIFLUNOMIDE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of teriflunomide
based on the number of shared cases.
Broader endpoints:
- MS-disease / Multiple Sclerosis
- Demyelinating diseases of the central nervous system
- L04AA Selective immunosuppressants
- Other degenerative diseases of the nervous system
- ILD medications: immunosuppressive drugs
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 312 | 235 | 77 |
| Unadjusted prevalence (%) | 0.08 | 0.10 | 0.04 |
| Mean age at first event (years) | 45.33 | 45.56 | 44.62 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: MSMED_TERIFLUNOMIDE – Use of teriflunomide
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of teriflunomide
↥Endpoint not on priority list, no data to show.